Skip to main content
Clinical Trials/DRKS00021602
DRKS00021602
Recruiting
N/A

A prospective study to evaluate clinical, neurophysiological and neuropsychological consequences of epilepsy surgery in patients with symptomatic focal epilepsy refractory to pharmacotherapy - ESCON (=Epilepsy Surgery Consequences)

niversitätsklinikum Göttingen Klinik für Anästhesiologie und Klinik für Neurologie0 sites25 target enrollmentMay 20, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
G40.2
Sponsor
niversitätsklinikum Göttingen Klinik für Anästhesiologie und Klinik für Neurologie
Enrollment
25
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Göttingen Klinik für Anästhesiologie und Klinik für Neurologie

Eligibility Criteria

Inclusion Criteria

  • Medication refractory epilepsy (as of current Guidelines of the ILAE);
  • \- Decision for resective epilepsy surgery based on an interdisciplinary case\-conference

Exclusion Criteria

  • Idiopathic generalized epilepsy

Outcomes

Primary Outcomes

Not specified

Similar Trials